الابحاث

South Egypt Cancer Institute

Assiut University

Department of Medical Oncology
# Title Research Member Research Year
81 Predictive and Prognostic Factors for the Outcome of the Patients Receiving Pegylated Liposomal Doxorubicin for Advanced Breast Cancer Dr. Abeer Elsayed Ali Ibrahim 2020
82 Expression of Estrogen receptor beta in Squamous cell carcinoma of bladder cancer Prof. Ashraf Zeidan Abdalla Ahmed 2020
83 Pegylated liposomal doxorubicin in patients with metastatic triple-negative breast cancer: 8-year experience of a single center Dr. Salah Mabrouk Khallaf Abd Rabou 2020
84 Evaluation the Possibility of Using of miRNA-21 as a Prognostic and Predictive Factor in Colorectal Cancer (South Egypt Experience)
 		Dr. Mayada Fawzy Sedik Farghaly 2020
85 4. Liposomal Doxorubicin based Chemotherapy in the treatment
of Relapsed Diffuse Large B-cell Lymphoma

 		Prof. Ashraf Zeidan Abdalla Ahmed 2020
86 4. Liposomal Doxorubicin based Chemotherapy in the treatment
of Relapsed Diffuse Large B-cell Lymphoma

 		Dr. Hanaan Ahmed Mohammed Ahmed 2020
87 Evaluation the Possibility of Using of miRNA-21 as a Prognostic and Predictive Factor in Colorectal Cancer (South Egypt Experience)
 		Dr. Abeer Elsayed Ali Ibrahim 2020
88 Evaluation the Possibility of Using of miRNA-21 as a Prognostic and Predictive Factor in Colorectal Cancer (South Egypt Experience)
 		Dr. Mayada Fawzy Sedik Farghaly 2020
89 Is survival with Conservative Breast Therapy becoming Superior to that with Modified Radical Mastectomy alone for the Treatment of Early Breast Cancer in this Era? Dr. Salah Mabrouk Khallaf Abd Rabou 2020
90 Pegylated liposomal doxorubicin in patients with metastatic triple-negative breast cancer: 8-year experience of a single center Yasmine Ali Roshdy 2020